Practice effects and the use of alternate forms in serial neuropsychological testing

Leigh J. Beglinger, Brenda Gaydos, Oranee Tangphao-Daniels, Kevin Duff, David Kareken, Jane Crawford, Philip S. Fastenau, Eric R. Siemers

Research output: Contribution to journalArticle

168 Citations (Scopus)

Abstract

Accurate understanding of practice characteristics, performance stability, and error on neuropsychological tests is essential to both valid clinical assessment and maximization of signal detection for clinical trials of cognitive enhancing drugs. We examined practice effects in 28 healthy adults. As part of a larger study using donepezil and simulating a Phase I trial, participants were randomized into: placebo, no-treatment and donepezil. Donepezil results are presented elsewhere. Neuropsychological tests were administered in a fixed order for 6 weeks, with alternate forms available for most tests. Despite alternate forms, ANOVAs revealed significant improvements for the pooled control group (placebo and no-treatment) on all tests except Letter Number Sequencing and Trails B. Learning occurred principally in the first three to four sessions. PASAT and Stroop interference showed the greatest learning. Thus, serial assessment with alternate forms may attenuate retest effects on some tests, but continued learning occurs on novel tests or those in which an advantageous test-taking strategy can be identified. Alternate forms and baseline practice sessions may help control early, rapid improvements in clinical trials.

Original languageEnglish
Pages (from-to)517-529
Number of pages13
JournalArchives of Clinical Neuropsychology
Volume20
Issue number4
DOIs
StatePublished - Jun 2005

Fingerprint

Neuropsychological Tests
Learning
Test Taking Skills
Placebos
Clinical Trials
Analysis of Variance
Control Groups
Therapeutics
Pharmaceutical Preparations
donepezil
Psychological Signal Detection

Keywords

  • Clinical trials
  • Cognition
  • Learning
  • Neuropsychological
  • Phase I
  • Practice effects

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology
  • Neuropsychology and Physiological Psychology

Cite this

Beglinger, L. J., Gaydos, B., Tangphao-Daniels, O., Duff, K., Kareken, D., Crawford, J., ... Siemers, E. R. (2005). Practice effects and the use of alternate forms in serial neuropsychological testing. Archives of Clinical Neuropsychology, 20(4), 517-529. https://doi.org/10.1016/j.acn.2004.12.003

Practice effects and the use of alternate forms in serial neuropsychological testing. / Beglinger, Leigh J.; Gaydos, Brenda; Tangphao-Daniels, Oranee; Duff, Kevin; Kareken, David; Crawford, Jane; Fastenau, Philip S.; Siemers, Eric R.

In: Archives of Clinical Neuropsychology, Vol. 20, No. 4, 06.2005, p. 517-529.

Research output: Contribution to journalArticle

Beglinger, LJ, Gaydos, B, Tangphao-Daniels, O, Duff, K, Kareken, D, Crawford, J, Fastenau, PS & Siemers, ER 2005, 'Practice effects and the use of alternate forms in serial neuropsychological testing', Archives of Clinical Neuropsychology, vol. 20, no. 4, pp. 517-529. https://doi.org/10.1016/j.acn.2004.12.003
Beglinger, Leigh J. ; Gaydos, Brenda ; Tangphao-Daniels, Oranee ; Duff, Kevin ; Kareken, David ; Crawford, Jane ; Fastenau, Philip S. ; Siemers, Eric R. / Practice effects and the use of alternate forms in serial neuropsychological testing. In: Archives of Clinical Neuropsychology. 2005 ; Vol. 20, No. 4. pp. 517-529.
@article{1c6f23cd599e475589c9207ff6dcb204,
title = "Practice effects and the use of alternate forms in serial neuropsychological testing",
abstract = "Accurate understanding of practice characteristics, performance stability, and error on neuropsychological tests is essential to both valid clinical assessment and maximization of signal detection for clinical trials of cognitive enhancing drugs. We examined practice effects in 28 healthy adults. As part of a larger study using donepezil and simulating a Phase I trial, participants were randomized into: placebo, no-treatment and donepezil. Donepezil results are presented elsewhere. Neuropsychological tests were administered in a fixed order for 6 weeks, with alternate forms available for most tests. Despite alternate forms, ANOVAs revealed significant improvements for the pooled control group (placebo and no-treatment) on all tests except Letter Number Sequencing and Trails B. Learning occurred principally in the first three to four sessions. PASAT and Stroop interference showed the greatest learning. Thus, serial assessment with alternate forms may attenuate retest effects on some tests, but continued learning occurs on novel tests or those in which an advantageous test-taking strategy can be identified. Alternate forms and baseline practice sessions may help control early, rapid improvements in clinical trials.",
keywords = "Clinical trials, Cognition, Learning, Neuropsychological, Phase I, Practice effects",
author = "Beglinger, {Leigh J.} and Brenda Gaydos and Oranee Tangphao-Daniels and Kevin Duff and David Kareken and Jane Crawford and Fastenau, {Philip S.} and Siemers, {Eric R.}",
year = "2005",
month = "6",
doi = "10.1016/j.acn.2004.12.003",
language = "English",
volume = "20",
pages = "517--529",
journal = "Archives of Clinical Neuropsychology",
issn = "1873-5843",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Practice effects and the use of alternate forms in serial neuropsychological testing

AU - Beglinger, Leigh J.

AU - Gaydos, Brenda

AU - Tangphao-Daniels, Oranee

AU - Duff, Kevin

AU - Kareken, David

AU - Crawford, Jane

AU - Fastenau, Philip S.

AU - Siemers, Eric R.

PY - 2005/6

Y1 - 2005/6

N2 - Accurate understanding of practice characteristics, performance stability, and error on neuropsychological tests is essential to both valid clinical assessment and maximization of signal detection for clinical trials of cognitive enhancing drugs. We examined practice effects in 28 healthy adults. As part of a larger study using donepezil and simulating a Phase I trial, participants were randomized into: placebo, no-treatment and donepezil. Donepezil results are presented elsewhere. Neuropsychological tests were administered in a fixed order for 6 weeks, with alternate forms available for most tests. Despite alternate forms, ANOVAs revealed significant improvements for the pooled control group (placebo and no-treatment) on all tests except Letter Number Sequencing and Trails B. Learning occurred principally in the first three to four sessions. PASAT and Stroop interference showed the greatest learning. Thus, serial assessment with alternate forms may attenuate retest effects on some tests, but continued learning occurs on novel tests or those in which an advantageous test-taking strategy can be identified. Alternate forms and baseline practice sessions may help control early, rapid improvements in clinical trials.

AB - Accurate understanding of practice characteristics, performance stability, and error on neuropsychological tests is essential to both valid clinical assessment and maximization of signal detection for clinical trials of cognitive enhancing drugs. We examined practice effects in 28 healthy adults. As part of a larger study using donepezil and simulating a Phase I trial, participants were randomized into: placebo, no-treatment and donepezil. Donepezil results are presented elsewhere. Neuropsychological tests were administered in a fixed order for 6 weeks, with alternate forms available for most tests. Despite alternate forms, ANOVAs revealed significant improvements for the pooled control group (placebo and no-treatment) on all tests except Letter Number Sequencing and Trails B. Learning occurred principally in the first three to four sessions. PASAT and Stroop interference showed the greatest learning. Thus, serial assessment with alternate forms may attenuate retest effects on some tests, but continued learning occurs on novel tests or those in which an advantageous test-taking strategy can be identified. Alternate forms and baseline practice sessions may help control early, rapid improvements in clinical trials.

KW - Clinical trials

KW - Cognition

KW - Learning

KW - Neuropsychological

KW - Phase I

KW - Practice effects

UR - http://www.scopus.com/inward/record.url?scp=19344364550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19344364550&partnerID=8YFLogxK

U2 - 10.1016/j.acn.2004.12.003

DO - 10.1016/j.acn.2004.12.003

M3 - Article

VL - 20

SP - 517

EP - 529

JO - Archives of Clinical Neuropsychology

JF - Archives of Clinical Neuropsychology

SN - 1873-5843

IS - 4

ER -